Methotrexat Teva Onco 50 mg/2 ml
Methotrexat Teva Onco 50 mg/2 ml is a medicine authorised by Swissmedic under authorisation number 47999. The authorisation holder is Teva Pharma AG. The medicinal product code is Synthetic medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 23 October 1987 and the authorisation is valid without a time limit. ATC code L01BA01 places the medicine in the group Antineoplastic agents.
| Authorisation number | 47999 |
|---|---|
| Name | Methotrexat Teva Onco 50 mg/2 ml |
| Full name | Methotrexat Teva Onco 50 mg/2 ml, Injektions-/Infusionslösung |
| Authorisation holder | Teva Pharma AG |
| Medicinal product code | Synthetic medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | L01BA01 |
| First authorisation | 23 October 1987 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Methotrexat Teva Onco 50 mg/2 ml, Injektions-/Infusionslösung | A | 23 October 1987 |
| 2 | Methotrexat Teva Onco 500 mg/20 ml, Injektions-/Infusionslösung | A | 23 October 1987 |
| 3 | Methotrexat Teva Onco 1000 mg/10 ml, Injektions-/Infusionslösung | A | 23 October 1987 |
| 4 | Methotrexat Teva Onco 5000 mg/50 ml, Injektions-/Infusionslösung | A | 23 October 1987 |
| 5 | Methotrexat Teva Onco 5 mg/2 ml, Injektions-/Infusionslösung | A | 21 December 2007 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | L01BA01 | 07.16.1. | A |
| 2 | 1 | Durchstechflasche(n) | L01BA01 | 07.16.1. | A |
| 3 | 1 | Durchstechflasche(n) | L01BA01 | 07.16.1. | A |
| 4 | 1 | Durchstechflasche(n) | L01BA01 | 07.16.1. | A |
| 5 | 1 | Durchstechflasche(n) | L01BA01 | 07.16.1. | A |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Methotrexat Teva Onco 50 mg/2 ml authorised in Switzerland?
Yes. Methotrexat Teva Onco 50 mg/2 ml is authorised by Swissmedic under authorisation number 47999, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Methotrexat Teva Onco 50 mg/2 ml have?
Methotrexat Teva Onco 50 mg/2 ml is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Methotrexat Teva Onco 50 mg/2 ml?
The authorisation holder is Teva Pharma AG. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.